ECRG4 inhibits growth and invasiveness of Squamous cell carcinoma of the head and neck in vitro and in vivo

Oncology Letters

Volumn 5, Issue 6, 2013, Pages 1921-1926

  Xu, Ting ^a   Xiao, Dajiang ^a   Zhang, Xin ^b  

^a WUXI NO 2 PEOPLE S HOSPITAL   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ECRG4; Growth; In vitro; In vivo; Metastasis; SCCHN

Indexed keywords

CELL PROTEIN; CYCLIN A; CYCLIN E; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL CULTURE; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; ECRG4 GENE; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; WESTERN BLOTTING;

EID: 84876492157     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1298     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
3. Hardisson D: Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 260: 502-508, 2003.
4. Gil Z and Fliss DM: Contemporary management of head and neck cancers. Isr Med Assoc J 11: 296-300, 2009.
5. Su T, Liu H and Lu S: Cloning and identification of cDNA fragments related to human esophageal cancer. Zhonghua Zhong Liu Za Zhi 20: 254-257, 1998 (In Chinese).
6. Yue CM, Deng DJ, Bi MX, Guo LP and Lu SH: Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma. World J Gastroenterol 9: 1174-1178, 2003.
7. Mori Y, Ishiguro H, Kuwabara Y, et al: Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Oncol Rep 18: 981-985, 2007.
8. Li LW, Yu XY, Yang Y, Zhang CP, Guo LP and Lu SH: Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo. Int J Cancer 125: 1505-1513, 2009.
9. Götze S, Feldhaus V, Traska T, et al: ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer 9: 447, 2009.
10. Vanaja DK, Ehrich M, Van den Boom D, et al: Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer Invest 27: 549-560, 2009.
11. Wang YB and Ba CF: Promoter methylation of esophageal cancer-related gene 4 in gastric cancer tissue and its clinical significance. Hepatogastroenterology 59: 1696-1698, 2012.
12. Matsuzaki J, Torigoe T, Hirohashi Y, et al: ECRG4 is a negative regulator of caspase-8-mediated apoptosis in human T-leukemia cells. Carcinogenesis 33: 996-1003, 2012.
13. Sabatier R, Finetti P, Adelaide J, et al: Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer. PLoS One 6: e27656, 2011.
14. Li LW, Li YY, Li XY, Zhang C P, Zhou Y and Lu SH: A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma. BMC Cancer 11: 52, 2011.
15. Zhang X, Liu Y, Gilcrease MZ, et al: A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 95: 1663-1672, 2002.
16. Lis R, Capdet J, Mirshahi P, et al: Oncologic trogocytosis with Hospicells induces the expression of N-cadherin by breast cancer cells. Int J Oncol 37: 1453-1461, 2010.
17. Tang J, Feng Y, Tsao S, Wang N, Curtain R and Wang Y: Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 126: 5-17, 2009.
18. Li W, Liu X, Zhang B, et al: Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion. J Exp Clin Cancer Res 29: 89, 2010.
19. Morgan DO: Principles of CDK regulation. Nature 374: 131-134, 1995.
20. Gross A, McDonnell JM and Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999.
21. Zhao JJ, Cheng H, Shidong J, et al: The p110a isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation. Proc Natl Acad Sci USA 103: 16296-16300, 2006.
22. Inoki K, Zhu T and Guan KL: TSC2 mediates cellular energy response to control cell growth and survival. Cell 115: 577-590, 2003.
23. Yao M, Epstein JB, Modi BJ, Pytynia KB, Mundt AJ and Feldman LE: Current surgical treatment of squamous cell carcinoma of the head and neck. Oral Oncol 43: 213-223, 2007.
24. Xu T, Yu CY, Sun JJ, et al: Bone morphogenetic protein-4-induced epithelial-mesenchymal transition and invasiveness through Smad1-mediated signal pathway in squamous cell carcinoma of the head and neck. Arch Med Res 42: 128-137, 2011.